A retrospective study assessing healthcare resource utilization and treatment patterns before and after initiation of Inhaled Treprostinil
Latest Information Update: 23 Dec 2021
Price :
$35 *
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension; Pulmonary hypertension
- Focus Therapeutic Use
- 23 Dec 2021 New trial record